BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2014-12-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 160
- Registration Number
- NCT00665054
Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 401
- Registration Number
- NCT00665327
Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2014-12-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1029
- Registration Number
- NCT00664833
Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 395
- Registration Number
- NCT00663845
Sorafenib Gastric Cancer Asian Phase I Study
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2013-06-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 13
- Registration Number
- NCT00663741
Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 759
- Registration Number
- NCT00663130
A Phase IV Study of Cipro XR in Uncomplicated UTI
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Bayer
- Target Recruit Count
- 7614
- Registration Number
- NCT00663806
A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 49
- Registration Number
- NCT00664326
Assessment of Duration of Erection With Vardenafil 10 mg
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 201
- Registration Number
- NCT00663728
Levitra® - Real Life Safety and Efficacy of Levitra
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 30825
- Registration Number
- NCT00663598
© Copyright 2024. All Rights Reserved by MedPath